Some of the information we have around this is from the current medical system, where we have some very large producers licensed and also some small mom-and-pop-style producers under licence. There's a general feeling that the illicit world, which includes many small growers, primarily in British Columbia but elsewhere, has been excluded. The fact is that they don't have the wherewithal to produce the security or they have legal issues that have been held against them, and there have been delays in licensing that have led mainly to the large producers with very deep investment funds to build facilities.
What we need to do in the commercial sense, outside the personal cultivation subject of this hearing, is to have an ecosystem in the same way we have with beer or wine, where you can have Molson and that type of thing as big ones and also have smaller producers that are equally well regulated, with testing applied and securities around there, that we also have regulations and legislation that encourage those small ones to get involved in this industry and not make the cost of start-up so steep or the regulations so strict that we exclude those small producers.